Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lynda Benmahammed"'
Autor:
Laurent Machet, Caroline Dutriaux, Nora Kramkimel, Laetitia Verdoni, Lionel Lattenist, Emilie Scherrer, Eve-Marie Neidhardt, Lynda Benmahammed-Bellagha, Philippe Saiag, Jean-Jacques Grob, Marie-Thérèse Leccia, Florent Grange, Anne-Bénédicte Duval-Modeste, F. Aubin, Laurent Mortier, Florence Brunet-Possenti, Caroline Robert, Axelle Spampinato, Olivier Dereure, Nicolas Meyer
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A338-A339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::806e3b340028ec80b40264dabe015990
https://doi.org/10.1016/j.fander.2021.09.405
https://doi.org/10.1016/j.fander.2021.09.405
Autor:
Nicolas Meyer, Caroline Dutriaux, Evelyne Boos, Catherine Hunault, Philippe Saiag, Laurent Mortier, Lynda Benmahammed
Publikováno v:
Journal of Clinical Oncology. 36:9563-9563
9563Background: Advanced mucosal melanoma is a rare subgroup of tumors for which few data on immune therapeutic approaches is available as they are rarely or not included in pivotal trials. Pembrol...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b60dcf7b5cc5b0f317ce2f815188a19
https://doi.org/10.1200/jco.2018.36.15_suppl.9563
https://doi.org/10.1200/jco.2018.36.15_suppl.9563
Autor:
Abir Tadmouri, Nicolas Meyer, Laurent Mortier, Catherine Hunault, Caroline Dutriaux, Lynda Benmahammed, Philippe Saiag, Ouzna Morsli, Marie Thérèse Leccia
Publikováno v:
Journal of Clinical Oncology. 36:9555-9555
9555Background: Information on the use of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma pts is limited although some data support a synergistic effect. Methods: We investigated the...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03d5e83bdb717a14813ab8c323596692
https://doi.org/10.1200/jco.2018.36.15_suppl.9555
https://doi.org/10.1200/jco.2018.36.15_suppl.9555
Autor:
Marie Thérèse Leccia, Philippe Saiag, Laurent Mortier, Lynda Benmahammed, Nicolas Meyer, Brigitte Dréno, Evelyne Boos, Caroline Dutriaux, Catherine Hunault
Publikováno v:
Journal of Clinical Oncology. 36:e21519-e21519
e21519Background: Pembrolizumab (PBZ), a monoclonal anti-PD1 antibody, has been approved in France as a first-line treatment of patients with advanced melanoma in Oct. 2015. Although this treatment...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb14f0525528639e74a4003d4c96663
https://doi.org/10.1200/jco.2018.36.15_suppl.e21519
https://doi.org/10.1200/jco.2018.36.15_suppl.e21519
Autor:
Amir Khammari, Marie Thérèse Leccia, Abir Tadmouri, Nicolas Meyer, Lynda Benmahammed, Caroline Dutriaux, Laurent Mortier, Catherine Hunault, Philippe Saiag
Publikováno v:
Journal of Clinical Oncology. 36:e21508-e21508
e21508Background: Pembrolizumab (PBZ), a monoclonal anti-PD-1, is approved in France since Oct 2015, as a first-line treatment of patients with advanced melanoma. Although this treatment was shown ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d0d4788f3035b4302ab131a81b9e2cf
https://doi.org/10.1200/jco.2018.36.15_suppl.e21508
https://doi.org/10.1200/jco.2018.36.15_suppl.e21508
Autor:
Even, Caroline1 (AUTHOR), Sagaon Teyssier, Luis2,3 (AUTHOR), Pointreau, Yoann4 (AUTHOR), Temam, Stéphane1 (AUTHOR), Huguet, Florence5 (AUTHOR), Geoffrois, Lionnel6 (AUTHOR), Schwarzinger, Michaël3 (AUTHOR) michael.schwarzinger@chu-bordeaux.fr
Publikováno v:
PLoS ONE. 2/3/2021, Vol. 16 Issue 2, p1-16. 16p.
Autor:
Schwarzinger, Michaël1,2 (AUTHOR) Michael.schwarzinger@transhealthecon.net, Luchini, Stéphane3 (AUTHOR), EPICORL Study Group (CORPORATE AUTHOR)
Publikováno v:
Health & Quality of Life Outcomes. 7/25/2019, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p.